Once midnight hits on New Year’s Eve there is little you can do about your 2017 tax bill. However, the author of today’s article points out that, right now, there is still time to shape what your tax position will be: “There are a number of actions you can take to help preserve gains, potentially defer taxes and possibly even reduce taxes.” The author proceeds to outline how each of the above can be accomplished using options strategies – as well as the risks and rewards of each strategy. CLICK HERE.
The goal of today’s article is identifying stocks that are high-yielding and which have the ability to sustain those high yields for years to come (with the latter being assessed by, among other criteria, whether the firms in question have significant, long-lasting competitive advantages). Specifically, the author highlights the ten cheapest stocks that meet this index’s criteria, as well as the most recent additions to the index – and the stocks that were most recently removed from the index after no longer making the cut. CLICK HERE.
With only 10% of drug candidates that reach the clinical trial stage eventually making their way onto the market, knowing which small biotechs to bet on for big gains is no easy feat for investors. The author of today’s article suggests that one way investors can increase their odds of success is by identifying small biotechs that are getting the attention (and money) of big pharma companies. He proceeds to highlight one such company, which “has developed an innovative product that makes other drugs more effective” – attracting capital from the likes of Roche, Johnson & Johnson and more. To read about this company, the science behind its technology – and the opportunity for investors – CLICK HERE.
Whether you see it as the deliberate sabotage of – or freeing the American people from – Obamacare, President Trump has recently taken a number of steps that upend the law. Meanwhile, Congressional Republicans seem to have moved on from their mission of repeal and replace. So what health care plays – if any – might investors want to consider in the current environment? The author of today’s article believes that the health care sector “remains a compelling long-term play” – and highlights five specific investments to consider. CLICK HERE.
Traditional ‘brick-and mortar’ retailers have been falling victim to the beast that is Amazon. However, some areas of the retail sector are viewed as being more insulated from Amazon – including discount retailers. One discount retailer in particular that investors may want to have on their radar is Big Lots. Today’s article looks at why Big Lots may be one of the best retail stocks to own – regardless of whether the retail sector stages a recovery or continues to struggle. To read more, CLICK HERE.
With low-priced stocks comes the potential for large returns. In fact, today’s article notes that stocks priced under $5 have the highest average return. Of course, low-priced stocks also come with high risk. As such, the author screened for low-priced stocks (trading under $5) with the potential to deliver large returns and employed additional earnings-based criteria in order to reduce risk. For seven stocks that passed this screen – including an oilfield technology stock, a payment and transaction processing stock, and a mining stock – CLICK HERE.
FANG stocks have been incredibly hot this year – and the exchange-traded fund highlighted in today’s article – which has demonstrated a penchant for strong fourth-quarter performances – could be an even bigger winner than usual as a result. The author notes that this ETF “has been one of the best performing U.S. ETFs during the last three months of the year since it debuted in mid 2006” – with an average fourth-quarter gain of 4.4%. To find out what this ETF is – and why it may be about to have its best showing in years – CLICK HERE.
After spending a good deal of time in near-obscurity, the author of today’s article observes that thematic ETFs – which are built around particular investment themes (e.g. 3D printing, wearable technology) deemed to have long-term implications – “are finally gaining acceptance and respect for their unique portfolio dynamics.” He proceeds to highlight several of this year’s top performing thematic ETFs – and how thematic ETFs may be best used in a portfolio. For more, CLICK HERE.
What would taking a bite of Apple mean for investors today? The author of today’s article believes that “investors should recognize how Apple has changed as an investment and think of investing in the company accordingly.” As such, he presents a “by the numbers” analysis of Apple’s historical performance based on fundamentals – and what that suggests for its future. How has the stock changed – and what is its investment merit going forward? CLICK HERE.
They are antiquated, expensive and usually fail to beat the market. This is the common wisdom on mutual funds – and not without good reason. However, the author of today’s article notes that, “while it’s true a lot of mutual funds have done poorly due to high fees, sloppy management and bad investments, there are plenty out there that have earned their fees, crushing index funds for years – and they’re still far outperforming the market.” He proceeds to highlight three such funds – each of which has been beating the broader market despite employing relatively conservative strategies. To read more, CLICK HERE.